Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...

Shares of enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) have received a consensus rating of “Buy” from the ten ...

Investors are rushing to invest in quantum computing, perhaps the next big idea to fuel the artificial intelligence ...

Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta ...

EDT Cathie Wood’s ARK Investment bought 171K shares of Tempus AI (TEM) todayLight Up your Portfolio with Spark:Easily identify stocks' ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...

The AI sector has been creating waves across financial markets, as recent news from DeepSeek adds fuel to an already ...

Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb.

We recently published a list of 11 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at ...